Conflicts of Interest

ALR, EMN, TG, and LS have no conflicts of interest to declare. TM is a board member of the International Papillomavirus Society. LLV reports grants from Merck & Co. and personal fees from Merck & Co. outside the submitted work. ELF reports grants to his institution from CIHR and the National Institutes of Health during the conduct of the study; and personal fees from Merck. MZ and ELF hold a patent related to the discovery “DNA methylation markers for early detection of cervical cancer”, registered at the Office of Innovation and Partnerships, McGill University, Montreal, Quebec, Canada.